Drug Profile
MT 7716
Alternative Names: MT-7716Latest Information Update: 10 May 2013
Price :
$50
*
At a glance
- Originator Mitsubishi Tanabe Pharma Corporation
- Class
- Mechanism of Action Nociceptin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Alcoholism
Most Recent Events
- 08 May 2013 Discontinued - Phase-I for Alcoholism in USA (unspecified route)
- 31 Oct 2011 Phase-I clinical trials in Alcoholism in USA (unspecified route)